2016 annual financial data
Voyager Therapeutics 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was -298.75%.
Operating income was -41,299,000 USD and net income was -40,193,000 USD.
Operating cash flow was -42,482,000 USD.
Get free Voyager Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,220,000 USD
- Operating income
- -41,299,000 USD
- Net income
- -40,193,000 USD
- Operating cash flow
- -42,482,000 USD